hemp Archives - Green Market Report

Kaitlin DomangueKaitlin DomangueOctober 30, 2019
USDA.jpg

5min4270

The United States Department of Agriculture has released a draft for the regulation of hemp in the US. The official rules will not be released yet. Geoff Whaling, chair of the National Hemp Association, says once the rules are released they will be temporary for the first year. This allows the states to participate in hemp cultivation and processing for the 2020 growing season. It also allows all stakeholders the opportunity to begin to implement the regulations and determine areas that need to be improved. 

“At USDA, we are always excited when there are new economic opportunities for our farmers, and we hope the ability to grow hemp will pave the way for new products and markets,” said Secretary Perdue. “We have had teams operating with all hands-on-deck to develop a regulatory framework that meets Congressional intent while seeking to provide a fair, consistent, and science-based process for states, tribes, and individual producers who want to participate in this program.”

From the draft, “under this new authority, a State or Indian Tribe that wants to have primary regulatory authority over the production of hemp in that State or territory of that Indian Tribe may submit, for the approval of the Secretary, a plan concerning the monitoring and regulation of such hemp production. For States or Indian Tribes that do not have approved plans, the Secretary is directed to establish a Departmental plan to monitor and regulate hemp production in those areas.”

The rules also cover other important things like where hemp can be grown, THC testing standards, biomass transportation, licensing regulations, and more. 

“The laboratories conducting hemp testing must be registered by the DEA to conduct chemical analysis of controlled substances (in accordance with 21 CFR 1301.13). Registration is 15 necessary because laboratories could potentially handle cannabis that tests above the 0.3% concentration of THC on a dry weight basis, which is, by definition, marijuana and a Schedule 1 controlled substance.” It also has been stated that there has been a consideration to establish a fee associated with hemp testing for THC. 

If a plant exceeds the legal level of THC, it must be disposed of properly. The draft states “if a producer has produced cannabis exceeding the acceptable hemp THC level, the material must be disposed of in accordance with the CSA and DEA regulations because such material constitutes marijuana, a schedule I controlled substance under the CSA. Consequently, the material must be collected for destruction by a person authorized under the CSA to handle marijuana, such as a DEA-registered reverse distributor, or a duly authorized Federal, State, or local law enforcement officer.”

There also many details within the drafted rules regarding licensing. “To produce hemp under the USDA plan, producers must apply for and be issued a license from USDA. USDA will begin accepting applications 30 days after the effective date of this interim rule. USDA is delaying acceptance of applications for 30 days to allow States and Tribal Governments to submit their plans first. This is to prevent USDA from reviewing and issuing USDA licenses to producers when there is a likelihood that there will soon be a State or Tribal plan in place and producers will obtain their licenses from the State or Tribe.”

It is exciting to see these rules finally being put into place so hemp can be well regulated in the United States. These guidelines should clear a lot of the gray areas that have been causing confusion about US hemp production, allowing for a better-regulated industry that will benefit the economy and community.

 


StaffStaffOctober 22, 2019
In-The-Moment-Kit-1280x893.jpg

8min3130

With the world in dire need of sustainable solutions to secure the future, hemp has understandably become one of the most valuable options for the job. As hemp is set to be a global commodity with economic prospects that even Wall Street is drooling over, innovation in this market is key. One start up has tackled an area for hemp that is arguably one of the smartest to focus on at the moment: Hospitality. The total retail value of the global hotel industry was projected to cross $500 Billion in 2018. The Total revenue of the hotel industry in the USA alone was projected at $200 Billion for 2018. So, introducing hemp to this industry could be a game changer. This is what the San Francisco based company MoonCloth Designs has decided to do.

Today MoonCloth Designs announced the launch of ‘MOMENT’, a Hemp Wellness Collection focused on bringing more eco-friendly hemp-based bath + body products to market. 

“We are driven to bring hemp into the sustainability spot light as an eco material solution. We started off working with hotels and spas to provide more sustainable solutions to their environments. We are now launching our own hemp wellness collection which showcases are beautiful hemp robes and hemp seed oil body products, which is now available on our online store and select retail partners,” explained Founder & CEO Sarah Harf.

Working with boutique and luxury hotels and hospitality brands like Soho House, Design Hotels, and Sensei Resorts, MoonCloth Designs is redefining the meaning of the word “wellness” by crafting elegant and sustainable solutions to hospitality environments, including custom hemp textiles design services and hotel room/spa amenities.

“By designing sustainable solutions using hemp, we can find beautiful and luxurious alternatives to synthetic body products, plastics, textiles, and positively change the future of our environment,” says MoonCloth Designs CEO & Founder, Sarah Harf. “Hemp seed oil and hemp fabric are great eco materials that allow us to create natural experiences without sacrificing design aesthetic.”

The critical component to MOMENT is the robustly regenerative plant hemp. Hemp purifies the soil of toxins like nitrogen and selenium, restores nutrients into the ground, and can sequester 1.62 tons of carbon dioxide for every ton harvest. Fibers made from hemp are anti-microbial, hypoallergenic, and free of synthetic materials and microplastics. Hemp seed oil is rich in omega-3 and omega-6 fatty acids, which help reduce inflammation and cell growth. It is also naturally hydrating and regulating the skin’s oil production.

“Our hemp-based products have tons of natural benefits for our bodies and our environment,” adds MoonCloth Designs Co-Founder Kelsi Lavicka.

Rooted in the daily practice of self-care and a love of natural beauty, MOMENT invites people to weave grounding moments into their daily lives by taking home the spa experience and aims to show the world that sustainability and high-end luxury are not mutually exclusive. 

The MOMENT wellness collection includes a multitude of luxurious hemp-inspired products, such as:

Moon Glow Oil – This potent and luxurious oil delivers long-lasting moisture for smooth and supple skin. Offering an abundant dose of antioxidants and high levels of omega’s; this synergistic blend of Hemp Seed Oil, Calendula and Rose is calming and regenerative, leaving you luminous.

Sacred Space Mist – A spritz for higher spirits, this transformative facial mist is equal parts skin tonic and mood regulator. Brimming with the potent yet calming benefits Hemp, Lavender, Patchouli and Clary Sage, this plant remedy will tone and brighten the skin and refresh your aura.

Tradition Hemp Silk Blend Kimono – Devoted to the long-time use of hemp and Japanese bathing culture, this hemp silk robe is luxury at its best. Uniquely blended with hemp and pure silk, free of harmful synthetic and polyester materials. Soft to the touch, this robe has a lightly weighted feel creating a beautiful shape as it falls against any body type. Other hemp robes in the MOMENT collection include natural hemp terry robe and a hemp fleece robe for men and women. 

In the MOMENT Kit + Hemp Cosmetic Bag – A complete hemp wellness package. The In the Moment Kit – Hemp Cosmetic Bag contains: 1 Meditation Oil in 10ml, 1 Moon Glow Oil in 30ml, 1 Sacred Space Mist in 30ml, 1 Restful Warrior Hemp Silk Eye Mask. All you need to take a pause and begin again. This kit features each item from the MOMENT collection, offering you a fully holistic experience. Designed to feed your skin, soothe your senses and keep you grounded on the go. Perfect for travel and whenever you need to focus and reconnect. 

With every MOMENT kit purchased, they are given 25% as a donation to ANIWA, a non profit event, produced by the BOA Foundation. ANIWA is focused on indigenous-lead projects including strategic land buy back, restoration of native ecosystems, reforestation, cultural exchange and sustainable living solutions. Hemp as regenerative plant that is a great solution for deforestation. Hemp produces more paper per acre than any other commercial forest . 

 


StaffStaffJuly 29, 2019
shutterstock_1093553171.jpg

14min34490

Guest submission from Ivan Green.

Hundreds of people have been benefited from using Cannabidiol (CBD) – a substance scientifically proven to be safe for human consumption – even for children! 

It not only has a wide range of therapeutic benefits but also has been useful for treating numerous serious ailments and disorders. 

However, not all products touted as “natural CBD oil” are actually as natural they claim to be. 

Natural CBD is admittedly safe. But they don’t include products that are made from synthetic lab-produced cannabinoids or contain contaminants, high levels of hallucinatory cannabinoids like Tetrahydrocannabinol (THC) or other harmful substances. 

Using such products will do more damage to you than simply making you fail a drug test. You can end up falling horribly sick or even dead! 

With the growing popularity of CBD products, some unscrupulous cannabis growers and CBD oil manufacturers are taking advantage of loopholes in the existing regulations and the vulnerabilities of the common man in this country to push their business forward with cheap, artificial and untested products in the name of CBD oil. 

Cheap Synthetic CBD 

From a once non-existent market category to a $1 billion industry, the hemp-derived CBD has become a booming industry today. 

But, it was disheartening to hear of 50 people falling severely ill after using CBD oil in Utah last year. It is worse when we find out that the oil that those people unwittingly smoked up thinking it was genuine CBD vape oil did not even contain any natural cannabinoid, but contained some lab-produced synthetic cannabinoids

The reason why people fall for these products are usually because of three reasons: 

  1. Their low price, 
  2. Tall promises of curing all health conditions, and 
  3. Claims of not being detected on a drug test. 

The unfortunate thing is these people were plain and simple duped! The company lied to its customers, and as a result, harmed them in ways that their unwary consumers were not prepared for. 

These dangerous designer drugs had prompted the US Centers for Disease Control and Prevention (CDC) to issue a nationwide health warning about these man-made synthetic cannabinoids. 

This is precisely why most reputed brands who sell genuine products are obligated to present their proof of their genuineness to their customers. They post the results of their products tested by third-party laboratories, also known as a Certificate of Analysis, which tests not only for synthetic components, but also other contaminants like heavy metals and pesticides and heavy metals as well as natural cannabinoids that possess hallucinatory effects, like THC (tetrahydrocannabinol, a natural cannabinoid found in cannabis plants).

Spice 

Known by different names – K2, Spice, Mr. Happy, Scooby Snax, and Kronic – is nothing but a group of lab-made synthetic cannabinoids that have been associated with a lot of people falling sick.

Originally designed by scientists for research, this drug is made from dried plant materials, sprayed with hallucinogenic chemicals. 

However, with the production method of this drug being published in scientific journals as part of their research, this knowledge also fell into the hands of some unscrupulous, over-ambitious drug makers, who used it to produce illicit drugs.

Once it hit the market, it came out as a new form of marijuana and people started rolling up the plant material into “joints” and smoking them like marijuana. 

This synthetic marijuana or fake weed is also sold in a liquid form that can be inhaled through a vape pen or mixed in tea to consume. 

Although these are man-made cannabinoids, it has the same effect on the human brain (especially the endocannabinoid system) as THC, but with far more intensity (even up to 100 times more intense). 

With no way to regulate them, there is no saying which hallucinogens are being used by the manufacturers to make their products.

The “Free” Scam 

Nothing in the CBD world is free. It simply can’t be. Manufacturing a bottle of genuine, natural CBD oil is expensive. If anybody tells you otherwise, be sure you are being tricked. 

While searching for CBD oil online, if you come across phrases like: 

  • Best Price, Limited Offer
  • Limited-Time Special Offer 
  • Special Discount For Only Today

Then be alert. Look up the brand and find out if their products are genuine. 

And if you see:

  • CBD oil free trial 
  • Or, they tell you to submit your credit card to free stuff 

DON’T BUY, REPORT. 

Some “free sample” offers are nothing more than hidden subscription ploy to force you to give away your credit/debit card details, which they will use to forcefully sell you low-quality products. You may even find it difficult to cancel the alleged subscription. You may have to call up your bank or credit card company to cancel their card to stop payments. 

Some other scammers will charge you more for what they are selling by simply calling it shipping and processing fee (while they send you a low-quality product). 

Quite a few reputed CBD brands offer quality products at a fair price. Do due diligence while looking for a CBD product and research on their makers. Find out everything you can about a company and the brand before you blindly fall for such “Free, Free, Free” lure. 

Pushing Hemp Seed Oil Instead of Hemp CBD 

Another reason for the confusion among users and abuse of the market is ignorance. Not only do you need to be wary about “fake CBD” and “free samples”, but you should also learn everything there is to know about how CBD is sourced and manufactured. 

If you have, you would know that hemp seed oil is not CBD oil derived from hemp. 

So, when you research on any brand, look for its ingredients on the label or their website. 

If it is Hempseed Oil, it will be listed as Cannabis Sativa Seed Oil.

If it is genuine CBD oil, you may see Cannabidiol, full-spectrum hemp, hemp oil, PCR (phytocannabinoid-rich) or PCR hemp extracts written on the label.

Also, look at their CoA for their products on their product webpages. 

Yes, they are lab tests, but not difficult for a layman to read and understand. It is meant for you, so it’s really quite simple. 

Hemp seed oil: Although a good carrier oil for CBD, it is not the same as CBD oil. So what is it? 

For that, you need to know where CBD oil is sourced. The best quality and most potent CBD oils are produced from hemp flowers. While the rest of the plant – like its leaves and shoots – may be used too. But, they have far less CBD content. 

The smaller seeds, in particular, have the least amount of it – traces at the best. Hemp seeds can be used to make hempseed milk or granola. They can also be cold-pressed to produce oil. But this oil is only good for cooking, making beauty products, or making paint. 

While hemp seed oil does have some benefits, like mild anti-inflammatory effects and skin moisturizer, it does not have sufficient levels of CBD to be called “CBD oil”. 

This means you would end up paying much for the product that it deserves. Intentionally or unintentionally, some companies try to push a cheaper product like hemp seed oil. 

Tricking Consumers with Products with low CBD content

Apart from hemp seed oil, there are other CBD products that don’t contain enough CBD to have any perceivable health benefits. 

Always look for the CBD content in mg on the label. This is the concentration of the CBD contained in the product. The total volume of the liquid does not guarantee CBD content. 

For instance, a 3 oz. bottle of tincture, priced at $50 and containing only 100 mg of CBD, may seem like a good deal. But, it is actually not. It is costing you $0.50/mg. A 1 oz. bottle, priced at $132 and containing 3000mg of CBD, is, in fact, a better deal ($0.04/mg). 

Making Sure You Get Quality Product 

By now, you must have understood that buying CBD oil isn’t as easy as you may have thought – click-click-click. 

You need to do a lot of research…

  • Research on how CBD oil is sourced, extracted, processed, purified, and the end product manufactured. 
  • Research on the companies and brands selling the products
  • Studying the CoAs, if they are provided by the companies. If they are not provided, they are obligated to provide one on request. 
  • Understanding the current market situation and the presence of synthetic cannabinoids, scammers, and cheap variants with tall claims.
  • The actual health benefits of CBD, so you don’t get lured by brands that make outrageous claims like curing cancer! 

Always make sure you get a high-quality CBD product when you place your order. Never let promotions, discounts or unrealistic claims fool you. 

When it comes to buying CBD, there is no bliss in ignorance, only suffering!


Debra BorchardtDebra BorchardtJune 19, 2019
CharlottesWeb.jpg

3min7910

Charlotte’s Web Holdings, Inc.  (TSX:CWEB)(OTCQX:CWBHF) reported its final hemp planting for its 2019 growing season. The company said that in order to meet growing demand the total acres planted for 2019 has been increased to 862, an 187% increase from 300 acres planted in 2018.

“Interest and demand for our products has been exceptional and growing rapidly. Our 2019 planting strategy ensures we will have the required raw materials to deliver on production targets for Charlotte’s Web products through 2020 and into 2021,” stated Deanie Elsner, CEO of Charlotte’s Web. “Our leading CBD hemp varieties under cultivation today are the foundation of our 2020 production plan.”

Charlotte’s Web said it uses an inventory model where it grows more hemp than it needs for the subsequent year to minimize the impact of farming risks and product shortfalls against forecasted rapid market growth. Dried hemp can be stored for years, with even more longevity in its extracted form. In 2016, 2017 and 2018, the company produced 41,000 lbs., 63,000 lbs. and 675,000 lbs., respectively, of dried hemp biomass.

A few weeks ago the company reported its earnings for the first quarter with revenue growing 66% to $21.7 million. The net income though dropped to $2.3 million from last year’s $3.1 million. The company delivered earnings per share that fell to $0.03 and diluted EPS of $0.02 versus last year’s $0.04. Operating expenses doubled from last year’s $6.4 million to this year’s $13.2 million.

Charlotte’s Web cultivates hemp outdoors in various regions across the United States to hedge against potential weather risks and other crop-related impacts. Of the 862 acres planted, 166 (19%) are in Colorado, 325 (38%) are in Kentucky, and 371 (43%) are in Oregon. The Colorado farms are operated by the company’s cultivation team while farms in Kentucky and Oregon employ family-owned contract farmers, supporting the important American agricultural economy through hemp farming.

All acres are cultivated using natural farming methods. An active supporter of organic farming, up to 457 acres, or 53% of the total acres planted for 2019 are designated for USDA organic certification, with additional organic expansion planned in subsequent years.

The company said it grows several hemp varieties, all of which contain high levels of CBD content but only trace THC amounts of less than 0.3%. Hemp varieties with high CBD potency reduce the amount of biomass required for CBD extracts, allowing for responsible farming practices by maximizing the production of cannabinoids, terpenes, and other beneficial botanical compounds.

 


Debra BorchardtDebra BorchardtJune 19, 2019
CannTrust3.png

3min5010

CannTrust Holdings Inc. (NYSE: CTST) shares popped over 5% in early trading on news that the company had formed a joint venture with California hemp grower Elk Grove Farming Company. CannTrust is a Canadian cannabis company founded by pharmacists and this would be the company’s entry into the United States. The company said it expects to invest roughly $20 million in the operation by the end of 2020. The shares were lately trading at $5.22.

CannTrust signed a non-binding Letter of Intent with Elk Grove that will provide access to over 3,000 acres of farmland for hemp production.  Elk Grove will be able to provide low-cost hemp with high cannabidiol (CBD) content. CannTrust and Elk Grove will each have 50% ownership of a new entity or joint venture.

The company said that prior to the commercial scale cultivation from the Joint Venture in 2020, CannTrust plans to execute on its processing strategy from the biomass produced from the Joint Venture, and its product development strategy. The company said that extracted product from the California operation in proprietary products has already been developed and that are ready for commercial production. The company specifically mentioned patented single-serve beverage pods.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity, which will leverage our expertise in standardized CBD-based product formulation, and will give the Company a foothold in the largest international CBD market in the world with an experienced and knowledgeable partner,” said Peter Aceto, Chief Executive Officer of CannTrust. “Following our successful equity offering, we have the liquidity we need to fund our ambitious growth plans including our greenhouse expansion in Niagara, our outdoor cultivation operation in British Columbia, our global footprint expansion and now our U.S. operation.”

According to the statement, Elk Grove has multi-generational experience in farming across a wide variety of commodities and value-added expertise in leading crop protection products, application, and input supply with operations throughout the State of California. “We are thrilled to be partnering with CannTrust. Our knowledge of farming operations in California coupled with CannTrust’s expertise in developing award-winning formulations is the perfect match to become a trusted supplier of CBD products in the U.S,” said Morgan Houchin of Elk Grove Farming Company.

 


Video StaffVideo StaffJune 4, 2019

1min7880

The Economics of the New Hemp Market is a panel that was held on May 7 at the Green Market Summit in Chicago. The legalization of hemp is so new that the regulations are still being written. Data will be key to unlocking this industry and industrial grade price assessments will be needed over the next few months to support futures trading on a major commodity exchange sometime early 2019. This panel was led by moderator Peter Vogel, CEO Leafwire and he was joined by Jonathan Rubin, Founder – Cannabis Benchmarks, Kevin Pilarski Chief Commercial Officer – Revolution and Bethany Gomez, Director of Research – Brightfield Group.


StaffStaffMay 14, 2019
hemp.jpg

4min5380

Hemptown Organics Corp. raised  C$24 million in a round of financing from Canaccord Genuity Corp.who served as the lead agent on the brokered portion of the financing on behalf of a syndicate of investors that included Sprott Capital, Beacon Securities, and Pacific International.

The investment will allow Hemptown to embark on a multi-state expansion, purchase $5.5M in Oregon CBD seeds, begin the build-out of its processing and extraction facilities, research team, as well as planting and harvesting of its 2019 crop of feminized hemp seeds.

“Successful companies in this sector will be those with the ability to build a scalable, vertically integrated multi-state company,” stated Rod Wolterman, Founder and Chairman, Hemptown USA. “We have assembled a well-respected team that has already produced some of the highest quality feminized hemp in the country here in Southern Oregon’s Emerald Triangle. The capital infusion will allow us to expand operations to Colorado, Kentucky, Northern California, ramp up processing capabilities and develop disruptive product formulations in the CPG sector. Needless to say, we’re very excited to be executing on our vision and delivering sustainably grown feminized hemp flower and biomass on a commercial scale.”

With this capital infusion, Hemptown USA is now poised to become a formidable multi-state operation within this rapidly growing industry. Hemptown reported that it had a first-year yield of 110,000 lbs of feminized hemp biomass. The company said it is one of the largest CBG producers in the U.S. with our purchase of 1 million rare CBG seeds for the 2019 growing season. It also said that it is producing some of the world’s most coveted strain profiles containing 15% – 20% full spectrum CBD, CBG and other cannabinoids and terpenes.

Currently, the company is growing 1500 acres in Oregon, Kentucky, and Colorado with the capability to more than double the acreage in 2020 and each year after.

Looking Ahead

Hemptown plans to continue farming more novel cannabinoid strains in large quantities. Such as CBC, CBDV, and CBGV. The company also plans on acquiring a cGMP nutraceutical facility to develop unique cannabinoid products for the health and wellness industry.

“Successful companies in this sector will be those with the ability to build a scalable, vertically integrated multi-state company,” stated Rod Wolterman, Founder and Chairman, Hemptown USA. “We have assembled a well-respected team that has already produced some of the highest quality feminized hemp in the country here in Southern Oregon’s Emerald Triangle. The capital infusion will allow us to expand operations to Colorado, Kentucky, Northern California, ramp up processing capabilities and develop disruptive product formulations in the CPG sector. Needless to say, we’re very excited to be executing on our vision and delivering sustainably grown  feminized hemp flower and biomass on a commercial scale.”

 

 


StaffStaffMay 9, 2019
img_hawaii.jpg

3min8730

Just two months after announcing the launch of Arcadia Specialty Genomics™, a new cannabis-dedicated division of agricultural crop improvement, the company has released images of its first crop of sun-grown, Hawaiian hemp. Arcadia’s new cannabis unit, cultivates six Hawaiian hemp strains on its 10-acre Hawaiian facility.

In March, the company revealed it had been granted an Industrial Hemp Pilot Program (“HIHPP”) License by Hawaii’s Department of Agriculture. The license allows for the cultivation of industrial hemp for the purposes of agricultural and academic research. Hemp and hemp products produced under the program may be commercially sold.

With a 10-acre field station in Hawaii, Arcadia is producing its first research crop of hemp to test the impact of climate and geography on crop parameters like yield and quality. Arcadia Specialty Genomics’ scientists and agronomists are evaluating and characterizing the performance of a number of local strains against various climate and biological conditions to understand the attributes of each, as well as identify opportunities for improvement. In addition, the company has hired full time staff at its Hawaii facility to oversee the ongoing research and grow operations.

“It’s highly gratifying to see our first hemp research crop taking root in Hawaii, having planted six different Hawaiian strains,” said Matt Plavan, president of Arcadia Specialty Genomics and CFO of Arcadia Biosciences. “In order to solve for crop variability – a major concern for U.S. hemp farmers – we first need to understand its drivers. We’re applying the sound, scientific approaches we’ve used to improve other crops, such as wheat, to create new breeds of superior hemp.”

Hawaii is the first state where Arcadia Specialty Genomics has commenced its research and cultivation of hemp in federal and state legal cannabis markets, using non-GMO techniques to produce superior U.S. hemp crops.

While traditional agricultural crops can be difficult to grow and export economically in Hawaii, the rich soil and warm climate are ideal for cultivating high-value crops such as hemp.

Arcadia Biosciences is a recognized leader bringing deep experience and established capabilities in this kind of crop innovation and optimization, delivering proven results safflower, wheat and durum such as:

A 100 percent increase in the production of omega-6 GLA for safflower
Two to six times more fiber than standard wheat and durum with its proprietary GoodWheat™ flour
A 65 percent reduction in allergenic gluten content in its GoodWheat™ flour
30 percent more lysine, an essential amino acid, in GoodWheat™ compared to standard wheat
The company expects to harvest its first crop of Hawaiian-grown research hemp this summer.

 

 


AxisWireAxisWireMay 7, 2019
img_hawaii2.jpg

8min7490

Arcadia Biosciences’ Hawaiian Hemp Farm in Full Bloom

Arcadia Specialty Genomics, the company’s new cannabis unit, cultivates six Hawaiian hemp strains on its 10-acre Hawaiian facility.

DAVIS, Calif. (May 7, 2019) /AxisWire/ – Just two months after announcing the launch of Arcadia Specialty Genomics™, a new cannabis-dedicated division of agricultural crop improvement leader Arcadia Biosciences, the company is releasing images of its first crop of sun-grown, Hawaiian hemp.

Arcadia Specialty Genomics focuses on the development of novel cannabis varieties possessing productivity, pest resistance and crop quality traits for license to cultivators in federal and state legal markets, and as products such as hemp-derived CBD oils for the nutraceutical and food industries.

In March, the company revealed it had been granted an Industrial Hemp Pilot Program (“HIHPP”) License by Hawaii’s Department of Agriculture. The license allows for the cultivation of industrial hemp for the purposes of agricultural and academic research. Hemp and hemp products produced under the program may be commercially sold.

With a 10-acre field station in Hawaii, Arcadia is producing its first research crop of hemp to test the impact of climate and geography on crop parameters like yield and quality. Arcadia Specialty Genomics’ scientists and agronomists are evaluating and characterizing the performance of a number of local strains against various climate and biological conditions to understand the attributes of each, as well as identify opportunities for improvement. In addition, the company has hired full time staff at its Hawaii facility to oversee the ongoing research and grow operations.

“It’s highly gratifying to see our first hemp research crop taking root in Hawaii, having planted six different Hawaiian strains,” said Matt Plavan, president of Arcadia Specialty Genomics and CFO of Arcadia Biosciences. “In order to solve for crop variability – a major concern for U.S. hemp farmers – we first need to understand its drivers. We’re applying the sound, scientific approaches we’ve used to improve other crops, such as wheat, to create new breeds of superior hemp.”

Hawaii is the first state where Arcadia Specialty Genomics has commenced its research and cultivation of hemp in federal and state legal cannabis markets, using non-GMO techniques to produce superior U.S. hemp crops.

While traditional agricultural crops can be difficult to grow and export economically in Hawaii, the rich soil and warm climate are ideal for cultivating high-value crops such as hemp.

Arcadia Biosciences is a recognized leader bringing deep experience and established capabilities in this kind of crop innovation and optimization, delivering proven results safflower, wheat and durum such as:

  • A 100 percent increase in the production of omega-6 GLA for safflower
  • Two to six times more fiber than standard wheat and durum with its proprietary GoodWheat™ flour
  • A 65 percent reduction in allergenic gluten content in its GoodWheat™ flour
  • 30 percent more lysine, an essential amino acid, in GoodWheat™ compared to standard wheat

The company expects to harvest its first crop of Hawaiian-grown research hemp this summer. For more information, visit www.arcadiabio.com.

About Arcadia Specialty Genomics

Arcadia Specialty Genomics is a strategic business unit of Arcadia Biosciences, Inc. leveraging the market-leading capabilities of its parent company to deliver crop innovation into developing proprietary, industry-leading cannabis germplasm. Focused on productivity, pest resistance and favored quality traits, Arcadia Specialty Genomics’ innovations serve the state- and federally-legal nutraceutical, food and industrial markets. For more information, visit www.arcadiaspecialtygenomics.com

About Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc. (Nasdaq: RKDA) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. Arcadia’s GoodWheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. The company’s agricultural traits are being developed to enable farmers around the world to be more productive and minimize the environmental impact of agriculture. For more information, visit www.arcadiabio.com.

Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: Arcadia Specialty Genomics’ expectations about the cannabis industry and potential demand for our products; the uncertainty of the laws and regulations relating to cannabis and products derived therefrom; the inherent uncertainty associated with the development of new projects; our ability to obtain proper licenses and successfully complete research programs related to cannabis; the acceptance of our products in the marketplace; the impact of competitive products and pricing;  risks related to costs, delays and uncertainties associated with potential future scientific research, product development, clinical trials and the regulatory approval process; our partners’ and affiliates’ ability to develop commercial products incorporating cannabis related traits, and complete the regulatory review process for such products; our compliance with laws and regulations that impact our business, and changes to such laws and regulations; our future capital requirements and ability to satisfy our capital needs; our ability to develop, enforce and defend our intellectual property rights; and the other risks set forth in our filings with the Securities and Exchange Commission from time to time, including the risks set forth in our Annual Report on Form 10-K for the year ended December 31, 2018 and other filings. These forward-looking statements speak only as of the date hereof, and Arcadia Biosciences, Inc. disclaims any obligation to update these forward-looking statements.

Twitter: @ArcadiaAg on Twitter
LinkedIn: Arcadia Biosciences

Press Contacts:

Trailblaze PR
Lisa Weser
lisa@trailblazepr.com


StaffStaffApril 30, 2019
Texas.jpg

4min5920

The Texas Tribune reported on Monday that the House of Representatives approved a bill that would decriminalize possession of cannabis. Rep. Joseph Moody (D), the chief sponsor of the bill, still had to amend it in order to get the bill approved. His original version had a lower fine of $250 and it would have dropped down low-level possession to a civil infraction instead of a class C misdemeanor.

Still, the paper reported that the chances of the bill turning into law would be slim. “After the House grants final approval for the bill — usually just a formality — it will head to the Senate, where presiding officer Lt. Gov. Dan Patrick has expressed opposition to the idea of loosening marijuana possession penalties.” The resistance is attributed to the fear that each move to loosen cannabis laws is another step towards full legalization.

If Texas manages to pass the law, it would become the 25th state to decriminalize cannabis. “Texans have suffered under failing marijuana policies for far too long,” Heather Fazio, director of Texans for Responsible Marijuana Policy, said. “Rep. Moody’s bill will help preserve valuable public safety resources and keep a marijuana charge from derailing someone’s life. Like a majority of Texas voters, Democratic and Republican lawmakers agree that marijuana laws need to change.”

Medical marijuana is legal in the state but on a very restrictive level. There is only one approved condition, which is intractable epilepsy. Several pieces of legislation have been filed in order to expand the condition list.

Hemp Farming Legalized

Just last week, The Texas House approved a bill that would allow farmers in the state to legally grow industrial hemp. House Bill 1325 from state Rep. Tracy King, D-Batesville, would also legalize hemp and hemp-derived extracts like CBD oil as long as they contain no more than 0.3% THC. “HB 1325 is right-to-farm legislation that will allow Texas farmers the opportunity to cultivate a drought-resistant cash crop — that being hemp,” King told other House members.

The bill has now headed to the Senate for approval. Texas Agriculture Commissioner Sid Miller is a strong supporter of industrial hemp production as a new market opportunity for Texas farmers to expand their operations and grow alternative crops.  Once authorized by the Legislature, TDA said it will create rules regarding licensing, production, testing, seed certification and other oversight as necessary.

“There’s no good reason for Texas farmers and ranchers not to have hemp as a crop option,” said Gene Hall, a spokesman for the Texas Farm Bureau. “I suspect a lot of farmers will choose this option once it’s available. It’s a drought-tolerant crop and can be grown anywhere where cropping is prevalent right now.”

 



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 4 hours

Charlotte’s Web Lowers Guidance As Expenses Skyrocket

@GreenMarketRpt – 9 hours

$CWEB $CEBHF ⁦@charlottesweb⁩ Lowers Guidance As Expenses Skyrocket #cbd…

Back to Top

You have Successfully Subscribed!